Bionano Genomics to Report First Quarter 2021 Financial Results and Host a Conference Call and Webcast on May 13, 2021
Bionano Genomics (BNGO) will host a conference call and webcast on May 13, 2021, at 4:30 p.m. ET to discuss its financial results for the first quarter ending March 31, 2021. This call will also highlight recent corporate progress. Interested participants can dial in using the listed toll-free number or view the webcast through the provided link. The company's Saphyr system enables advanced genome analysis for genetic research and diagnostic testing, particularly in autism spectrum disorders.
- The Saphyr system offers ultra-sensitive structural variation detection, which is crucial for genetic diagnostics.
- None.
SAN DIEGO, May 06, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Thursday, May 13, 2021 at 4:30 p.m. Eastern Time to report financial results for the first quarter ended March 31, 2021 and to highlight recent corporate progress.
Conference call & Webcast Details
| Date: | Thursday, May 13, 2021 |
| Time: | 4:30 p.m. Eastern Time |
| Toll Free: | (833) 397-0959 |
| International: | (614) 999-1719 |
| Conference ID: | 7163806 |
| Webcast: | https://edge.media-server.com/mmc/p/5hjudqv7 |
To access the call, participants should dial the applicable telephone number above at least 5 minutes prior to the start of the call. An archived version of the webcast will be available for replay in the Investors section of the Bionano website.
About Bionano Genomics
Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. Bionano’s Saphyr system is a research use only platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system is comprised of an instrument, chip consumables, reagents and a suite of data analysis tools. Bionano provides genome analysis services to provide access to data generated by the Saphyr system for researchers who prefer not to adopt the Saphyr system in their labs. Lineagen has been providing genetic testing services to families and their healthcare providers for over nine years and has performed over 65,000 tests for those with neurodevelopmental concerns. For more information, visit www.bionanogenomics.com or www.lineagen.com.
CONTACTS
Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionanogenomics.com
Investor Relations and
Media Contact:
Amy Conrad
Juniper Point
+1 (858) 366-3243
amy@juniper-point.com
FAQ
When is Bionano Genomics' next earnings call?
What is the purpose of Bionano Genomics' conference call?
How can I access Bionano Genomics' conference call?
